iScience · 2026
Temporal and transcriptional programming of effector memory B cells shapes vaccine platform-dependent humoral immunity.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nellore Anoma, Fucile Christopher, Scharer Christopher D, Murray Page, Geer Jack T, Lemonds Jacey, Mousseau Betty, Zhou Fen, Zumaquero Esther, Akhter Jobaida, Ivanova Ellie, Navarro Valeria Estrada, Goepfert Paul A, Duerr Ralf, Herati Ramin S, Rosenberg Alexander D, Lund Frances E, Randall Troy D
Аннотация
This study investigates how influenza vaccine platform shapes the memory B cell responses that underlie durable antibody protection. Using fluorescent hemagglutinin (HA) probes, the authors compared HA-specific IgD-negative B cells in adults who received either live attenuated influenza vaccine (LAIV) or inactivated influenza vaccine (IIV). Both platforms induced circulating T-bet+ HA+ B cells with similar phenotypic features, but their relationship to antibody outcomes diverged sharply: while these cells track with durable IgG responses after IIV, only early (day 7-14) T-bet+ HA+ B cell frequencies predicted durable IgA responses after LAIV. Single-cell transcriptional profiling further revealed that LAIV and IIV elicit distinct effector-memory B cell states, including an LAIV-enriched, terminally differentiated TBX21/ZEB2-high population with limited plasmablast recall potential. Together, these findings show that influenza vaccination drives platform-dependent diversification of HA-specific B cell states, highlighting the need for vaccine-platform-specific correlates of immune protection.